医学
胆道癌
胆道
内科学
免疫组织化学
胃肠病学
癌症
肿瘤科
病理
临床试验
临床研究阶段
作者
Shubham Pant,Jia Fan,Do-Youn Oh,Hye Jin Choi,Jin Won Kim,Heung Moon Chang,Lequn Bao,HUI-CHUAN SUN,Teresa Macarulla,Feng Xie,Jean-Phillippe Metges,Jie'er Ying,John Bridgewater,Myung-Ah Lee,Mohamedtaki A Tejani,Emerson Y. Chen,Harpreet Wasan,Michel Ducreux,Yuanyuan Bao,Xiaotian Wu
标识
DOI：10.1001/jamaoncol.2025.4736
摘要
This follow-up analysis of the phase 2 HERIZON-BTC-01 trial evaluates the efficacy, patient-reported outcomes, and safety profile of zanidatamab in patients with ERBB2 -amplified biliary tract cancer with an HER2 immunohistochemistry score of 3+ or 2+ after 33 months of follow-up.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
OsamaKareem
学术文献互助
无极微光
MchemG
贪玩的秋柔
YifanWang
大力的灵雁
靤君
Hayat
缓慢怜菡
Rita
morena
loii
mmyhn
Criminology34
云飞扬
strike
8R60d8
AllRightReserved
皖公网安备34019202002308
